These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Arnsten JH; Demas PA; Grant RW; Gourevitch MN; Farzadegan H; Howard AA; Schoenbaum EE J Gen Intern Med; 2002 May; 17(5):377-81. PubMed ID: 12047736 [TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Arnsten JH; Demas PA; Farzadegan H; Grant RW; Gourevitch MN; Chang CJ; Buono D; Eckholdt H; Howard AA; Schoenbaum EE Clin Infect Dis; 2001 Oct; 33(8):1417-23. PubMed ID: 11550118 [TBL] [Abstract][Full Text] [Related]
5. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408 [TBL] [Abstract][Full Text] [Related]
6. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117 [TBL] [Abstract][Full Text] [Related]
7. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis. Azar P; Wood E; Nguyen P; Luma M; Montaner J; Kerr T; Milloy MJ BMC Infect Dis; 2015 Apr; 15():193. PubMed ID: 25927573 [TBL] [Abstract][Full Text] [Related]
8. Sequential antiretroviral adherence measurement using electronic bottle cap monitors in a cohort of HIV-infected adults. Shuter J; Sarlo JA; Stubbs RO; Rode RA; Zingman BS J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):94-7. PubMed ID: 22223595 [TBL] [Abstract][Full Text] [Related]
9. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents. Martin S; Elliott-DeSorbo DK; Wolters PL; Toledo-Tamula MA; Roby G; Zeichner S; Wood LV Pediatr Infect Dis J; 2007 Jan; 26(1):61-7. PubMed ID: 17195708 [TBL] [Abstract][Full Text] [Related]
10. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Kapadia F; Vlahov D; Wu Y; Cohen MH; Greenblatt RM; Howard AA; Cook JA; Goparaju L; Golub E; Richardson J; Wilson TE Am J Drug Alcohol Abuse; 2008; 34(2):161-70. PubMed ID: 18293232 [TBL] [Abstract][Full Text] [Related]
11. Medication adherence in patients with HIV infection: a comparison of two measurement methods. Melbourne KM; Geletko SM; Brown SL; Willey-Lessne C; Chase S; Fisher A AIDS Read; 1999 Aug; 9(5):329-38. PubMed ID: 12737122 [TBL] [Abstract][Full Text] [Related]
12. The impact of illicit drug use and substance abuse treatment on adherence to HAART. Hicks PL; Mulvey KP; Chander G; Fleishman JA; Josephs JS; Korthuis PT; Hellinger J; Gaist P; Gebo KA; AIDS Care; 2007 Oct; 19(9):1134-40. PubMed ID: 18058397 [TBL] [Abstract][Full Text] [Related]
13. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial. Haug NA; Sorensen JL; Lollo ND; Gruber VA; Delucchi KL; Hall SM AIDS Care; 2005 Nov; 17(8):1022-9. PubMed ID: 16176898 [TBL] [Abstract][Full Text] [Related]
14. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Malta M; Strathdee SA; Magnanini MM; Bastos FI Addiction; 2008 Aug; 103(8):1242-57. PubMed ID: 18855813 [TBL] [Abstract][Full Text] [Related]
15. Illicit drug use: can it predict adherence to antiretroviral therapy? Martini M; Recchia E; Nasta P; Castanotto D; Chiaffarino F; Parazzini F; Agnoletto V Eur J Epidemiol; 2004; 19(6):585-7. PubMed ID: 15330132 [TBL] [Abstract][Full Text] [Related]
16. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project. Parsons JT; Rosof E; Punzalan JC; Di Maria L AIDS Patient Care STDS; 2005 Jan; 19(1):31-9. PubMed ID: 15665633 [TBL] [Abstract][Full Text] [Related]
17. Theory- and evidence-based intervention to improve adherence to antiretroviral therapy among HIV-infected patients in the Netherlands: a pilot study. de Bruin M; Hospers HJ; van den Borne HW; Kok G; Prins JM AIDS Patient Care STDS; 2005 Jun; 19(6):384-94. PubMed ID: 15989434 [TBL] [Abstract][Full Text] [Related]
18. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903 [TBL] [Abstract][Full Text] [Related]
19. Type and pattern of illicit drug use and access to health care services for HIV-infected people. Sohler NL; Wong MD; Cunningham WE; Cabral H; Drainoni ML; Cunningham CO AIDS Patient Care STDS; 2007; 21 Suppl 1():S68-76. PubMed ID: 17563292 [TBL] [Abstract][Full Text] [Related]
20. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. Wagner GJ AIDS Patient Care STDS; 2002 Dec; 16(12):599-608. PubMed ID: 12542933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]